Genomic Health - 48 Year Dividend Yield History | GHDX

Historical dividend payout and yield for Genomic Health (GHDX) since 1971. The current TTM dividend payout for Genomic Health (GHDX) as of February 15, 2019 is $0.00. The current dividend yield for Genomic Health as of February 15, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.945B $0.341B
Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It launched its first test, Oncotype DX, which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The Oncotype DX assay represents the first diagnostic gene expression test on the market that provides consistent results across multiple independent trials having breast cancer patients, including a large validation study of The New England Journal of Medicine.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.167B 12.95
Gilead Sciences (GILD) United States $85.858B 10.77
Bio-Techne Corp (TECH) United States $7.121B 47.98